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licenseHemorrhage: A strong indicator for myomectomy-related
complicationUterine fibroid (leiomyoma or myoma) is the most common
benign uterine tumor, accounting for 20e60% of cases in
women of reproductive age.1 Three variant-subcategories
include: (1) ordinary leiomyomadbenign, including non-
degenerated and degenerated [cystic, hemorrhagic (carneous),
fatty (lipoleiomyoma), hyaline, and myxoids]; (2) leiomyoma
variantsdunclassified (mitotically active, cellular, atypical,
and smooth muscle tumors of uncertain malignant potential);
and (3) leiomyosarcomadmalignant.2 The use of a uterine-
preservation strategy, including medical or surgical treatment
rather than hysterectomy, to treat uterine myoma has become
popular, because it not only provides adequate symptom
control, but also preserves fertility.3e5 Advanced surgical
instruments, including new and innovative laparoscopic tech-
niques with and without robotics-assisted systems, have
allowed a greater number of gynecologic surgeons to use
laparoscopic surgery in place of conventional exploratory
laparotomy in the management of various kinds of diseases,
including some gynecological malignancies.6e8 Furthermore,
these so-called minimally invasive surgeries claim to have
many patient-focused benefits, such as a decreasing risk of
postoperative adhesion, promoting rapid recovery, and cos-
metic advantages.9 However, the malignant form (leiomyo-
sarcoma) is difficult to differentially diagnose clearly between
benign and malignant tumors, resulting in an almost impos-
sible presurgical diagnosis and contributing to the elevated
possibility of widespread malignant tumors during and after
operation, especially for those surgeries using morcellation.
An increasing number of surgeons are hesitant, and some are
outright opposed, to this approach in the management of
uterine fibroids. Therefore, conventional laparotomy has
regained a measure of popularity.10e12 Moreover, as surgical
techniques have continued to advance, it is now possible to
shorten the incision wound (ultramini-laparotomy), enabling
patients to receive benefits similar to those of traditional lap-
aroscopic surgery.11,12 Therefore, abdominal myomectomy is
still considered the best choice for women with fibroids and
who need to maintain their reproductive function.10,11
The study by Çinar et al13 in this issue of the Journal of the
Chinese Medical Association entitled, “Association of clinical
outcomes and complications with obesity in patients whox.doi.org/10.1016/j.jcma.2016.02.004
901/Copyright © 2016, the Chinese Medical Association. Published by El
(http://creativecommons.org/licenses/by-nc-nd/4.0/).underwent abdominal myomectomy,” investigated the out-
comes of obese women who underwent abdominal myomec-
tomy. The authors separated their patients into two groups:
those with a body mass index (BMI) > 30 kg/m2 (n ¼ 90;
obese women), and those with a BMI  30 kg/m2 (n ¼ 183;
controls). The authors found that obese women had a sig-
nificantly higher risk of both early and late complications
relative to the controls (15.6% vs. 7.7%, p ¼ 0.046; and 26.7%
vs. 1.1%, p < 0.001, respectively), contributing to a longer
hospital stay (3.3 ± 1.8 days vs. 2.8 ± 1.0 days, p ¼ 0.001).
Furthermore, the logistic regression model used to identify the
association between BMI and the occurrence of both early and
late complications showed a positive correlation, with an odds
ratio (OR) of 1.446 [95% confidence interval (CI)
1.218e1.717). However, it was interesting to note that non-
serosal type contributed to an even higher degree of positive
correlation (OR 5.875, 95% CI 1.557e22.160), suggesting
that the disease itself may play a critical role in the develop-
ment of both early and late complications. After further
analysis, we found that hemorrhage during operation was the
most common early-type complication in both obese and
nonobese women undergoing abdominal myomectomy, which
occurred in 7% of all women, regardless of BMI. It is well
known that tumor size, location, and operative time contribute
to increased blood loss (hemorrhage) during operation. Our
findings might explain why the authors showed that
nonserosal-type uterine fibroids were the most significant
predictive factors of increases in both early and late compli-
cations. Furthermore, we also noted that obese women had
larger uterine fibroids relative to the controls. Additionally,
there was concurrence that tumor characteristics could be
much more important and an independent factor used to pre-
dict complications in women who plan to receive abdominal
myomectomy. Unfortunately, the authors failed to note this
result, and, by contrast, only emphasized obesity as a risk
factor for complications in women who were treated with
abdominal myomectomy. Did the obese women have BMI-
related complications? Our answer is “yes”. From the
authors' data, we found that wound infection might be rela-
tively specific to obese women, because more than one-tenth
of obese women were complicated with wound infectionsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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relatively specific complication in obese women was ileus
(13.3% vs. 0.5%); it is unfortunate that the authors did not
make this specific finding.
In fact, women who underwent myomectomy could be
medically managed by various types of procedures to minimize
blood loss during operation.14,15 Hemorrhage not only results
in an immediate life-threatened situation, but also contributes
to many subsequent sequelae, including risk of blood trans-
fusion, infection and possible adhesion, ileus, and delayed
recovery. However, the authors did not consider hemorrhage
as a key factor when discussing the association between
complications and obesity. We believed that any reasonable
strategy was necessary to minimize blood loss when we
performed the surgery, and stanched all bleeders with much
more certainty, as well as cleaned the blood debris before
wound closure. This would be a key factor in decreasing the
development of both early and late complications, including
Dr Çinar's study13 in this issue of JCMA. The gold standard
to minimize surgery-related complication is “a delicate oper-
ation” with the assistance of more effective and powerful
surgical instruments and gentle techniques.
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